• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE - VIENNA FLOSEAL HEMOSTATIC MATRIX; AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE - VIENNA FLOSEAL HEMOSTATIC MATRIX; AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED Back to Search Results
Catalog Number 1501510
Device Problem Insufficient Information (3190)
Patient Problems Adhesion(s) (1695); Reaction (2414)
Event Date 02/14/2014
Event Type  Injury  
Event Description
It was reported from a hospital that a patient experienced unintended intestinal adhesion caused ileus after laparoscopic cysts extraction in which floseal was used.It was noted that floseal was rinsed amply and the histological report showed adhesion by foreign body reaction which occurred 10 days after the use of floseal.Sample or batch number is not available.No further information provided.
 
Manufacturer Narrative
(b)(4).Baxter medical assessment: inflammatory response with foreign body reaction and adhesion formation may occur after use of floseal.In most instances this occurs in cases in which the excess hemostatic matrix (product not reacted with the blood) is not properly irrigated, or in cases in which product is applied too slowly and/or not approximated properly for 2 minutes.This may lead to imbibitions of excess floseal with blood, and even copious irrigation is not able to remove excess product.We cannot exclude that floseal has caused or contributed to the inflammatory reaction with adhesion formation and foreign body reaction.A follow-up report will be submitted upon receipt and evaluation of additional information.
 
Manufacturer Narrative
(b)(4).Baxter (b)(4) completed the investigation.Sample evaluation could not be performed as no sample was provided.Batch review was performed and all released products met specifications and no nonconformities, failures, rework or deviations were found.No trend was identified.Per vienna, no further investigation is required as the complaint is an expected and foreseeable side effect which is described in the product labeling.This is the first complaint of this nature received for this product lot.The case will be kept on file for trending purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLOSEAL HEMOSTATIC MATRIX
Type of Device
AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED
Manufacturer (Section D)
BAXTER HEALTHCARE - VIENNA
industriestrasse 67
vienna 1220
AU  1220
Manufacturer (Section G)
BAXTER HEALTHCARE - VIENNA
industriestrasse 67
vienna 1220
AU   1220
Manufacturer Contact
kimberly crane
one baxter way
westlake village, CA 91362
8053723182
MDR Report Key3665592
MDR Text Key17164486
Report Number2032282-2014-00045
Device Sequence Number1
Product Code LMF
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
P990009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 02/25/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/06/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date10/31/2014
Device Catalogue Number1501510
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/14/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-